<DOC>
	<DOCNO>NCT02279888</DOCNO>
	<brief_summary>The purpose CardioMEMS HF System Post Approval Study ( PAS ) evaluate use CardioMEMS HF System patient NYHA class III heart failure commercial setting .</brief_summary>
	<brief_title>CardioMEMS HF System Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Diagnosis NYHA class III heart failure At least 1 heart failure hospitalization within previous 12 month Patients reduce LVEF heart failure receive beta blocker 3 month ACEI ARB one month unless investigator 's opinion , patient intolerant beta blocker , ACEI ARB BMI ≤ 35 . Patients BMI &gt; 35 require chest circumference measure axillary level . If &gt; 65 inch patient eligible study . Pulmonary artery branch diameter ≥ 7mm ( implant target artery assess right heart catheterization ) Active infection History recurrent ( &gt; 1 ) pulmonary embolism deep vein thrombosis Inability tolerate right heart catheterization A major cardiovascular event ( e.g. , myocardial infarction , open heart surgery , stroke , etc . ) within previous 2 month Cardiac resynchronization device ( CRT ) implant within previous 3 month Glomerular Filtration Rate ( GFR ) &lt; 25 ml/min ( obtain within 2 week implant ) nonresponsive diuretic therapy chronic renal dialysis Congenital heart disease mechanical right heart valve Likely undergo heart transplantation VAD within next 6 month Known coagulation disorder Hypersensitivity allergy aspirin , and/or clopidogrel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pulmonary Artery Pressure Monitoring</keyword>
	<keyword>Implantable Hemodynamic Monitor</keyword>
</DOC>